Document is current
Any future updates will be listed below
-
Authors
Schnitzler, Gavin R.
Kang, Helen https://orcid.org/0000-0001-9522-1911
Fang, Shi
Angom, Ramcharan S. https://orcid.org/0000-0002-5894-1108
Lee-Kim, Vivian S.
Ma, X. Rosa https://orcid.org/0000-0001-8297-4279
Zhou, Ronghao
Zeng, Tony
Guo, Katherine
Taylor, Martin S. https://orcid.org/0000-0003-1560-9276
Vellarikkal, Shamsudheen K.
Barry, Aurelie E.
Sias-Garcia, Oscar
Bloemendal, Alex
Munson, Glen
Guckelberger, Philine https://orcid.org/0000-0002-1057-2518
Nguyen, Tung H.
Bergman, Drew T. https://orcid.org/0000-0002-8314-7088
Hinshaw, Stephen
Cheng, Nathan
Cleary, Brian https://orcid.org/0000-0003-0825-7129
Aragam, Krishna https://orcid.org/0000-0003-3223-9131
Lander, Eric S.
Finucane, Hilary K. https://orcid.org/0000-0003-3864-9828
Mukhopadhyay, Debabrata https://orcid.org/0000-0003-1858-5054
Gupta, Rajat M. https://orcid.org/0000-0001-9865-4106
Engreitz, Jesse M. https://orcid.org/0000-0002-5754-1719
- License Information
-
More Information
Article History
Received: 17 October 2022
Accepted: 3 January 2024
First Online: 7 February 2024
Competing interests
: J.M.E. is a shareholder of Illumina and 10X Genomics, has received materials from 10X Genomics unrelated to this work, is an equity holder in and consultant for Martingale Labs, and has received guest speaker honoraria from GSK. M.S.T. holds equity and has received consulting fees from ROME Therapeutics, which is not related to this work. G.R.S., R.M.G., J.M.E., H.K. and X.R.M. are inventors on a provisional patent related to this work. All other authors declare no competing interests.
